Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897117 · ClinicalTrials.gov registry record
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
A clinical trial of Lung Cancer, sponsored by Vanderbilt-Ingram Cancer Center.
- Recruiting
- Registry status
- 4,000
- Enrollment target
- 3
- Study locations
NCT00897117 is a study of Lung Cancer that is actively recruiting participants, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 4,000 participants, above the 926-participant average among 409 other Lung Cancer trials with a reported enrollment target (332% higher). The trial reports 3 study locations across 1 state.
The verdict
NCT00897117, a study of Lung Cancer, is actively recruiting participants, sponsored by Vanderbilt-Ingram Cancer Center.
- RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 3
- Study locations
Study Summary
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that may occur in RNA and identify biomarkers related to cancer. PURPOSE: This research study is collecting and analyzing lung tissue samples from patients undergoing surgery for non-small cell lung cancer.
Conditions Studied
Interventions
- GENETIC gene expression analysis
- GENETIC microarray analysis
- GENETIC protein expression analysis
- OTHER biologic sample preservation procedure
- OTHER laboratory biomarker analysis
Study Locations (3)
Tennessee
- Dan Rudy Cancer Center at Saint Thomas Hospital - Nashville
- Veterans Affairs Medical Center - Nashville - Nashville
- Vanderbilt-Ingram Cancer Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2001-05 |
| Est. Completion | 2031-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00897117
The ClinicalTrials.gov registry entry for NCT00897117 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 926-participant average among 409 other Lung Cancer trials with a reported enrollment target (332% higher). The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 5 interventions - of which gene expression analysis is the first listed.
NCT00897117 reports 3 study locations spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT00897117 about?
NCT00897117 is a clinical study titled "Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer". RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that may occur in RNA and identify biomarkers related to cancer. PURPOSE: This research study is collecting and analyzing lung tissue samples from patients undergoing su...
What is the current status of trial NCT00897117?
This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2001-05. Estimated completion is 2031-05-31.
What conditions does trial NCT00897117 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT00897117?
The interventions under investigation include: gene expression analysis (GENETIC), microarray analysis (GENETIC), protein expression analysis (GENETIC), biologic sample preservation procedure (OTHER), laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT00897117?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00897117 being conducted?
This trial has 3 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.